EP Patent

EP4233873A3 — Implantable scaffolds for treatment of sinusitis

Assigned to Lyra Therapeutics Inc · Expires 2023-10-18 · 3y expired

What this patent protects

This disclosure describes, inter alia, materials, devices, kits and methods that may be used to treat chronic sinusitis.

USPTO Abstract

This disclosure describes, inter alia, materials, devices, kits and methods that may be used to treat chronic sinusitis.

Drugs covered by this patent

Patent Metadata

Patent number
EP4233873A3
Jurisdiction
EP
Classification
—
Expires
2023-10-18
Drug substance claim
No
Drug product claim
No
Assignee
Lyra Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.